Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The genetic architecture of ALS
Aleksey Shatunov, Ammar Al‐Chalabi
Neurobiology of Disease (2020) Vol. 147, pp. 105156-105156
Open Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

Antisense oligonucleotide silencing of FUS expression as a therapeutic approach in amyotrophic lateral sclerosis
Vladislav A. Korobeynikov, Alexander K. Lyashchenko, Beatriz Blanco-Redondo, et al.
Nature Medicine (2022) Vol. 28, Iss. 1, pp. 104-116
Open Access | Times Cited: 190
FUS-ALS hiPSC-derived astrocytes impair human motor units through both gain-of-toxicity and loss-of-support mechanisms
Katarina Stoklund Dittlau, Lisanne Terrie, Pieter Baatsen, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 45
Genome-wide association analysis of stalk biomass and anatomical traits in maize
Mona Mazaheri, Marlies Heckwolf, Brieanne Vaillancourt, et al.
BMC Plant Biology (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 109
Nearly 30 Years of Animal Models to Study Amyotrophic Lateral Sclerosis: A Historical Overview and Future Perspectives
Tiziana Bonifacino, Roberta Arianna Zerbo, Matilde Balbi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12236-12236
Open Access | Times Cited: 64
Pharmacotherapy for Amyotrophic Lateral Sclerosis: A Review of Approved and Upcoming Agents
Stephen A. Johnson, Ton Fang, Fabiola De Marchi, et al.
Drugs (2022) Vol. 82, Iss. 13, pp. 1367-1388
Closed Access | Times Cited: 64
Role of SNAREs in Neurodegenerative Diseases
Azzurra Margiotta
Cells (2021) Vol. 10, Iss. 5, pp. 991-991
Open Access | Times Cited: 58
Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases
Giulia Gentile, Giovanna Morello, Valentina La Cognata, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 5, pp. 770-770
Open Access | Times Cited: 48
Wearable device and smartphone data quantify ALS progression and may provide novel outcome measures
Stephen A. Johnson, Marta Karas, Katherine M. Burke, et al.
npj Digital Medicine (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 32
Whole blood transcriptome profile identifies motor neurone disease RNA biomarker signatures
Sulev Kõks, Karin Rallmann, Mari Muldmaa, et al.
Experimental Biology and Medicine (2025) Vol. 249
Open Access | Times Cited: 1
Short tandem repeat expansions in sporadic amyotrophic lateral sclerosis and frontotemporal dementia
Lyndal Henden, Liam G. Fearnley, Natalie Grima, et al.
Science Advances (2023) Vol. 9, Iss. 18
Open Access | Times Cited: 20
Modulation of the gut–brain axis via the gut microbiota: a new era in treatment of amyotrophic lateral sclerosis
Hong Du, Chi Zhang, Wenshuo Wu, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 18
Tracking amyotrophic lateral sclerosis disease progression using passively collected smartphone sensor data
Marta Karas, Julia Olsen, Marcin Strączkiewicz, et al.
Annals of Clinical and Translational Neurology (2024) Vol. 11, Iss. 6, pp. 1380-1392
Open Access | Times Cited: 7
Autophagy regulation by acetylation—implications for neurodegenerative diseases
Sung Min Son, So Jung Park, Marian Fernandez-Estévez, et al.
Experimental & Molecular Medicine (2021) Vol. 53, Iss. 1, pp. 30-41
Open Access | Times Cited: 40
Why should we care about astrocytes in a motor neuron disease?
Katarina Stoklund Dittlau, Ludo Van Den Bosch
Frontiers in Molecular Medicine (2023) Vol. 3
Open Access | Times Cited: 15
Pathological insights from amyotrophic lateral sclerosis animal models: comparisons, limitations, and challenges
Longhong Zhu, Shihua Li, Xiao‐Jiang Li, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 15
Pan-neuronal expression of human mutant SOD1 in Drosophila impairs survival and motor performance, induces early neuroinflammation and chromosome aberrations
Francesco Liguori, Francesca Alberti, Susanna Amadio, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 5, pp. 167192-167192
Open Access | Times Cited: 5
Mapping the future of oxidative RNA damage in neurodegeneration: Rethinking the status quo with new tools
H. O. Wheeler, Assael A. Madrigal, Isaac A. Chaim
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 46
Open Access | Times Cited: 4
Where and Why Modeling Amyotrophic Lateral Sclerosis
Francesco Liguori, Susanna Amadio, Cinzia Volonté
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 3977-3977
Open Access | Times Cited: 27
Amyotrophic Lateral Sclerosis Genes in Drosophila melanogaster
Sophie Layalle, Laetitia They, Sarah Ourghani, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 904-904
Open Access | Times Cited: 26
Reactive astrocytes in ALS display diminished intron retention
Oliver J. Ziff, Doaa M. Taha, Hamish Crerar, et al.
Nucleic Acids Research (2021) Vol. 49, Iss. 6, pp. 3168-3184
Open Access | Times Cited: 26
Calculating variant penetrance from family history of disease and average family size in population-scale data
Thomas P Spargo, Sarah Opie-Martin, Harry Bowles, et al.
Genome Medicine (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 18
Brain distribution study of [14C]-Riluzole following intranasal administration in mice
Rafal S Baker, Julie Wang, Nadia Rouatbi, et al.
International Journal of Pharmaceutics (2025) Vol. 670, pp. 125195-125195
Open Access
Circulating miR-223/NLRP3 axis and IL-1β level in functional disease progression of amyotrophic lateral sclerosis
Mitra Ansari Dezfouli, Davood Shalilahmadi, Gholamreza Shamsaei, et al.
Acta Neurologica Belgica (2025)
Closed Access
The role of autophagy in the pathogenesis and treatment of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD)
Jimmy Beckers, Philip Van Damme
Autophagy Reports (2025) Vol. 4, Iss. 1
Open Access
The genetics of motor neuron disease in New Zealand
Miran Mrkela, Miriam Rodrigues, Serey Naidoo, et al.
Journal of the Neurological Sciences (2025), pp. 123472-123472
Closed Access
Page 1 - Next Page

Scroll to top